Market Focus Turns to Sandisk, Revolution Medicines, and McKesson Earnings
LAS VEGAS, NV / CRWE PRESS RELEASE / August 2, 2026 - Among the companies set to release financial results on Wednesday, August 5, are:
Sandisk Corporation (Nasdaq: SNDK) is scheduled to release its fiscal fourth-quarter and full fiscal year 2026 financial results after the market closes. Wall Street analysts expect earnings of $34.51 per share on revenue of approximately $8.39 billion. $SNDK ended Friday's session at $1,214.83, declining $65.13, or 5.09%.
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on targeted therapies for cancer, will report second-quarter 2026 results following the closing bell. Consensus estimates call for a loss of $2.06 per share on revenue of $15.47 million. $RVMD closed Friday at $187.53, down $4.64, or 2.41%.
McKesson Corporation (NYSE: MCK), one of the largest healthcare supply chain and pharmaceutical distribution companies in the United States, is set to announce first-quarter fiscal 2027 financial results after regular trading concludes. Analysts are forecasting earnings of $9.54 per share on revenue of $103.74 billion. $MCK finished Friday's session at $856.19, slipping $9.32, or 1.08%.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
© 2026 CRWE PRESS RELEASE. All Rights Reserved.
